| Keryx Biopharmaceuticals to Present at the J.P. Morgan 28th Annual Healthcare ... - PR Newswire (press release) |
|
|
PR Newswire (press release)The Phase 3 clinical program of Zerenex in the treatment for hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease is ... read more |